Sho Ikeda

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

Future oncology (London, England)

Cancer science

International journal of hematology

Blood advances

This page only lists publications with an associated author ORCID identifier.

Publications

Masahiro Yamada, Sho Ikeda, Wataru Kuroki, Sayaka Iwama, Yuto Takahashi, Akihiro Kitadate, Hiroyuki Tagawa, Naoto Takahashi
Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect. International journal of hematology (2024)
Yu Abe, Shiro Kubonishi, Masaki Ri, Masaki Iino, Kazutaka Sunami, Tomoki Ito, Masafumi Fukaya, Toshiyuki Kitano, Sho Ikeda, Shuichi Ota, Taiga Kuroi, Noriyoshi Iriyama, Tatsuro Jo, Masaaki Adachi, Daigo Akahane, Tatsuyuki Kai, Yoichi Kohara, Norimitsu Kadowaki, Teruaki Katayama
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future oncology (London, England) (2024)
Yu Abe, Shiro Kubonishi, Masaki Ri, Masaki Iino, Kazutaka Sunami, Tomoki Ito, Masafumi Fukaya, Toshiyuki Kitano, Sho Ikeda, Shuichi Ota, Taiga Kuroi, Noriyoshi Iriyama, Tatsuro Jo, Masaaki Adachi, Daigo Akahane, Tatsuyuki Kai, Yoichi Kohara, Norimitsu Kadowaki, Teruaki Katayama
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future oncology (London, England) (2024)
Masahiro Yamada, Sho Ikeda, Wataru Kuroki, Sayaka Iwama, Yuto Takahashi, Akihiro Kitadate, Hiroyuki Tagawa, Naoto Takahashi
Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect. International journal of hematology 120 (3) (2024)
Yu Abe, Shiro Kubonishi, Masaki Ri, Masaki Iino, Kazutaka Sunami, Tomoki Ito, Masafumi Fukaya, Toshiyuki Kitano, Sho Ikeda, Shuichi Ota, Taiga Kuroi, Noriyoshi Iriyama, Tatsuro Jo, Masaaki Adachi, Daigo Akahane, Tatsuyuki Kai, Yoichi Kohara, Norimitsu Kadowaki, Teruaki Katayama
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future oncology (London, England) 20 (17) (2024)
Yu Abe, Shiro Kubonishi, Masaki Ri, Masaki Iino, Kazutaka Sunami, Tomoki Ito, Masafumi Fukaya, Toshiyuki Kitano, Sho Ikeda, Shuichi Ota, Taiga Kuroi, Noriyoshi Iriyama, Tatsuro Jo, Masaaki Adachi, Daigo Akahane, Tatsuyuki Kai, Yoichi Kohara, Norimitsu Kadowaki, Teruaki Katayama
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future oncology (London, England) 20 (17) (2024)
Yu Abe, Shiro Kubonishi, Masaki Ri, Masaki Iino, Kazutaka Sunami, Tomoki Ito, Masafumi Fukaya, Toshiyuki Kitano, Sho Ikeda, Shuichi Ota, Taiga Kuroi, Noriyoshi Iriyama, Tatsuro Jo, Masaaki Adachi, Daigo Akahane, Tatsuyuki Kai, Yoichi Kohara, Norimitsu Kadowaki, Teruaki Katayama
An observational study of once-weekly carfilzomib in patients with multiple myeloma in Japan (Weekly-CAR study). Future oncology (London, England) 20 (17) (2024)
Masahiro Yamada, Sho Ikeda, Wataru Kuroki, Sayaka Iwama, Yuto Takahashi, Akihiro Kitadate, Hiroyuki Tagawa, Naoto Takahashi
Comprehensive analysis of microRNAs modulated by histone deacetylase inhibitors identifies microRNA-7-5p with anti-myeloma effect. International journal of hematology 120 (3) (2024)
Ko Abe, Sho Ikeda, Miho Nara, Akihiro Kitadate, Hiroyuki Tagawa, Naoto Takahashi
Hypoxia-induced oxidative stress promotes therapy resistance via upregulation of heme oxygenase-1 in multiple myeloma. Cancer medicine (2023)
Yuka Matsuda, Sho Ikeda, Fumito Abe, Yuto Takahashi, Akihiro Kitadate, Naoto Takahashi, Hideki Wakui, Hiroyuki Tagawa
Downregulation of miR-26 promotes invasion and metastasis via targeting interleukin-22 in cutaneous T-cell lymphoma. Cancer science 113 (4) (2022)
Sho Ikeda, Hiroyuki Tagawa
Impact of hypoxia on the pathogenesis and therapy resistance in multiple myeloma. Cancer science 112 (10) (2021)
Akihiro Kitadate, Toshiki Terao, Kentaro Narita, Sho Ikeda, Yuto Takahashi, Takafumi Tsushima, Daisuke Miura, Masami Takeuchi, Naoto Takahashi, Matsue Kosei
Multiple myeloma with t(11;14)-associated immature phenotype has lower CD38 expression and higher BCL2 dependence. Cancer science 112 (9) (2021)
Sho Ikeda, Fumito Abe, Yuka Matsuda, Akihiro Kitadate, Naoto Takahashi, Hiroyuki Tagawa
Hypoxia-inducible hexokinase-2 enhances anti-apoptotic function via activating autophagy in multiple myeloma. Cancer science 111 (11) (2020)
Sho Ikeda, Akihiro Kitadate, Fumito Abe, Naoto Takahashi, Hiroyuki Tagawa
Hypoxia-inducible KDM3A addiction in multiple myeloma. Blood advances 2 (4) (2019)
Sho Ikeda, Akihiro Kitadate, Fumito Abe, Hirobumi Saitoh, Yoshihiro Michishita, Yoshiaki Hatano, Yoshinari Kawabata, Atsushi Kitabayashi, Kazuaki Teshima, Masaaki Kume, Naoto Takahashi, Hiroyuki Tagawa
Hypoxia-inducible microRNA-210 regulates the DIMT1-IRF4 oncogenic axis in multiple myeloma. Cancer science 108 (4) (2017)

Sho Ikeda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sho Ikeda